Skyward Specialty Insurance Group, Inc.·4

May 8, 4:22 PM ET

Ashe Gena L 4

4 · Skyward Specialty Insurance Group, Inc. · Filed May 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Skyward (SKWD) Director Gena L. Ashe Receives RSU Award

What Happened

  • Gena L. Ashe, a director of Skyward Specialty Insurance Group, was granted 3,334 restricted stock units (RSUs) on May 6, 2026. The Form 4 reports the award as a derivative grant (transaction code A) with a reported acquisition price of $0.00. Each RSU represents the right to receive one share of common stock upon vesting. According to the award agreement, the RSUs will fully vest on the date of the issuer's 2027 Annual Meeting of Shareholders.

Key Details

  • Transaction date: 2026-05-06; Form 4 filed: 2026-05-08 (timely filing).
  • Transaction type/code: Grant/Award (derivative) — 3,334 RSUs; reported price $0.00.
  • Vesting: Fully vests on the issuer’s 2027 Annual Meeting of Shareholders (per footnote).
  • Shares owned after transaction: not specified in the filing.
  • Footnotes: F1 clarifies 1 RSU = right to 1 share upon vesting; F2 describes the grant and vesting schedule.
  • No sale or purchase of shares occurred—this is compensation, not an open-market trade.

Context

  • RSU grants are a common form of non-cash compensation for executives and directors; they do not represent immediately tradable shares until they vest and are settled. Such awards are routine and do not by themselves indicate a buy or sell signal.

Insider Transaction Report

Form 4
Period: 2026-05-06
Ashe Gena L
Director
Transactions
  • Award

    2026 RSU Award

    [F1][F2]
    2026-05-06+3,3343,334 total
    Common Stock (3,334 underlying)
Holdings
  • Common Stock

    3,513
Footnotes (2)
  • [F1]Each RSU represents the right to receive, after vesting and upon settlement, one share of Common Stock of the Issuer.
  • [F2]On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,334 RSUs. Subject to the terms of the award agreement, this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders.
Signature
/s/ Stacy E. Skelton, Attorney-in-Fact|2026-05-08

Documents

1 file
  • 4
    form4-05082026_080518.xmlPrimary